Amgen报告收入有9.4%的强劲增长,尽管分析师大多对股票保持“持有”评级。 Amgen reported a strong 9.4% revenue rise, though analysts mostly maintain a "hold" rating on the stock.

NC在Amgen Inc.(AMGN)的股份增加了3.3%,而Kaizen金融战略将其股份增加了35.9%。 Guardian Wealth Advisors LLC NC increased its stake in Amgen Inc. (AMGN) by 3.3%, while Kaizen Financial Strategies boosted its holdings by 35.9%. Amgen报告,全年收入增长9.4%,达到81.5亿美元,收入估计数为7.72美元,EPS为4.90美元。 Amgen reported a 9.4% revenue increase year-over-year to $8.15 billion and beat earnings estimates by $0.72, with EPS at $4.90. 该公司的股份大部分从分析师那里获得了“持有”评级,目标价格约为310.23美元。 The company's shares have garnered mostly "hold" ratings from analysts, with a target price of around $310.23. Amgen在全球发展和销售人类治疗药物。 Amgen develops and sells human therapeutics globally.